These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22705322)

  • 1. Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance.
    Moreno-Navarrete JM; Ortega F; Sánchez-Garrido MÁ; Sabater M; Ricart W; Zorzano A; Tena-Sempere M; Fernández-Real JM
    J Nutr Biochem; 2013 Jan; 24(1):32-8. PubMed ID: 22705322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual dimorphism in the molecular mechanisms of insulin resistance during a critical developmental window in Wistar rats.
    Ortiz-Huidobro RI; Larqué C; Velasco M; Chávez-Maldonado JP; Sabido J; Sanchez-Zamora YI; Hiriart M
    Cell Commun Signal; 2022 Oct; 20(1):154. PubMed ID: 36224569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased STAMP2 expression in association with visceral adipose tissue dysfunction.
    Moreno-Navarrete JM; Ortega F; Serrano M; Pérez-Pérez R; Sabater M; Ricart W; Tinahones F; Peral B; Fernández-Real JM
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1816-25. PubMed ID: 21849520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expression.
    Ortega FJ; Serrano M; Rodriguez-Cuenca S; Moreno-Navarrete JM; Gómez-Serrano M; Sabater M; Rodriguez-Hermosa JI; Xifra G; Ricart W; Peral B; Vidal-Puig A; Fernández-Real JM
    J Mol Med (Berl); 2015 Jan; 93(1):83-92. PubMed ID: 25249007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.
    Um SH; Frigerio F; Watanabe M; Picard F; Joaquin M; Sticker M; Fumagalli S; Allegrini PR; Kozma SC; Auwerx J; Thomas G
    Nature; 2004 Sep; 431(7005):200-5. PubMed ID: 15306821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance.
    Balage M; Dupont J; Mothe-Satney I; Tesseraud S; Mosoni L; Dardevet D
    J Nutr Biochem; 2011 Mar; 22(3):219-26. PubMed ID: 20558053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of metabolic effects of rosiglitazone.
    Seda O; Sedová L; Oliyarnyk O; Kazdová L; Krenová D; Corbeil G; Hamet P; Tremblay J; Kren V
    Pharmacogenomics; 2008 Feb; 9(2):141-55. PubMed ID: 18370844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
    Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue.
    Lynch CJ; Patson BJ; Anthony J; Vaval A; Jefferson LS; Vary TC
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E503-13. PubMed ID: 12169444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance.
    Moreno-Navarrete JM; Touskova V; Sabater M; Mraz M; Drapalova J; Ortega F; Serrano M; Catalán V; Gómez-Ambrosi J; Ortiz MR; Pardo G; Pueyo N; Ricart W; Lacinova Z; Haluzik M; Frühbeck G; Fernández-Real JM
    Int J Obes (Lond); 2013 Sep; 37(9):1230-7. PubMed ID: 23318725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression.
    Ortega FJ; Moreno-Navarrete JM; Mayas D; Serino M; Rodriguez-Hermosa JI; Ricart W; Luche E; Burcelin R; Tinahones FJ; Frühbeck G; Mingrone G; Fernández-Real JM
    Int J Obes (Lond); 2014 May; 38(5):737-45. PubMed ID: 23999197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities.
    Miranda M; Ceperuelo-Mallafré V; Lecube A; Hernandez C; Chacon MR; Fort JM; Gallart L; Baena-Fustegueras JA; Simó R; Vendrell J
    Metabolism; 2009 Dec; 58(12):1762-8. PubMed ID: 19615702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement factor H is expressed in adipose tissue in association with insulin resistance.
    Moreno-Navarrete JM; Martínez-Barricarte R; Catalán V; Sabater M; Gómez-Ambrosi J; Ortega FJ; Ricart W; Blüher M; Frühbeck G; Rodríguez de Cordoba S; Fernández-Real JM
    Diabetes; 2010 Jan; 59(1):200-9. PubMed ID: 19833879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
    Virtanen KA; Hällsten K; Parkkola R; Janatuinen T; Lönnqvist F; Viljanen T; Rönnemaa T; Knuuti J; Huupponen R; Lönnroth P; Nuutila P
    Diabetes; 2003 Feb; 52(2):283-90. PubMed ID: 12540598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Whole-Body Fat Mass Produced by Chronic Alcohol Consumption is Associated with Activation of S6K1-Mediated Protein Synthesis and Increased Autophagy in Epididymal White Adipose Tissue.
    Crowell KT; Steiner JL; Coleman CS; Lang CH
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1832-45. PubMed ID: 27464336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
    McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.
    Tiikkainen M; Häkkinen AM; Korsheninnikova E; Nyman T; Mäkimattila S; Yki-Järvinen H
    Diabetes; 2004 Aug; 53(8):2169-76. PubMed ID: 15277403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoxia improves carbohydrate metabolism by browning of white adipocytes in obese type 2 diabetic rats.
    Norouzirad R; Ghanbari M; Bahadoran Z; Abdollahifar MA; Rasouli N; Ghasemi A
    Life Sci; 2019 Mar; 220():58-68. PubMed ID: 30703383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.